tradingkey.logo
搜索

BioLife Solutions Inc

BLFS
添加自选
31.280USD
-0.360-1.14%
收盘 07-31 16:00美东报价延迟15分钟
1.53B总市值
亏损市盈率 TTM

关于 BioLife Solutions Inc 公司

BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.

BioLife Solutions Inc简介

公司代码BLFS
公司名称BioLife Solutions Inc
上市日期Nov 22, 1989
CEODe Greef (Roderick)
员工数量159
证券类型Ordinary Share
年结日Nov 22
公司地址Suite 310
城市BOTHELL
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编98021
电话14254011400
网址https://www.biolifesolutions.com/
公司代码BLFS
上市日期Nov 22, 1989
CEODe Greef (Roderick)

BioLife Solutions Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
292.27K
-0.18%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
131.22K
-0.64%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
66.03K
-154.97%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
65.47K
-1.76%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
47.56K
-0.58%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
44.99K
-2.88%
Ms. Catherine (Cathy) Coste, CPA
Ms. Catherine (Cathy) Coste, CPA
Independent Director
Independent Director
5.70K
-143.31%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Amy Duross
Ms. Amy Duross
Lead Independent Director
Lead Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
292.27K
-0.18%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
131.22K
-0.64%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
66.03K
-154.97%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
65.47K
-1.76%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
47.56K
-0.58%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
44.99K
-2.88%

常见问题

BioLife Solutions Inc的前五大股东是谁?

BioLife Solutions Inc 的前五大股东如下:Dr. Aby J. Mathew, Ph.D.

有多少机构持有BioLife Solutions Inc(BLFS)的股份?

截至2026Q1,共有430家机构持有BioLife Solutions Inc的股份,合计持有的股份价值约为51.34M,占公司总股份的105.07%。与2025Q4相比,机构持股有所增加,增幅为-1261408.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有